Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.16 USD | +0.06% | +10.46% | +2.83% |
04-25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Sales 2024 * | 535M 728M | Sales 2025 * | 577M 785M | Capitalization | 852M 1.16B |
---|---|---|---|---|---|
Net income 2024 * | 43M 58.46M | Net income 2025 * | 57M 77.5M | EV / Sales 2024 * | 1.84 x |
Net Debt 2024 * | 132M 179M | Net Debt 2025 * | 79M 107M | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
15.1
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.99% |
Latest transcript on Core Laboratories Inc.
1 day | +0.06% | ||
1 week | +10.46% | ||
Current month | +14.94% | ||
1 month | +4.49% | ||
3 months | +22.13% | ||
6 months | -6.20% | ||
Current year | +2.83% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 18.16 | +0.06% | 318,037 |
24-05-14 | 18.15 | +4.43% | 600,281 |
24-05-13 | 17.38 | +2.24% | 367,290 |
24-05-10 | 17 | -0.53% | 421,327 |
24-05-09 | 17.09 | +3.95% | 326,416 |
Delayed Quote Nyse, May 15, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.83% | 851M | |
+11.91% | 16.98B | |
0.00% | 7.34B | |
-10.61% | 2.77B | |
-30.24% | 1.79B | |
-3.73% | 1.15B | |
-4.78% | 1.07B | |
-12.62% | 821M | |
0.00% | 756M | |
-18.97% | 737M |
- Stock Market
- Equities
- CLB Stock